According to a recent LinkedIn post from Nabla, the company’s Chief Medical Officer moderated a roundtable at HIMSS2026 focused on the evolution from ambient AI, which documents clinical encounters, to agentic AI that can act within clinical workflows. The discussion reportedly covered an “autonomy ladder” for healthcare AI, governance and trust hurdles, and early use cases in revenue cycle, care coordination, and patient safety.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that health systems are beginning to build on governance frameworks originally developed for ambient AI as a basis for deploying more autonomous, agentic systems. For investors, this focus on governance, workflow integration, and next‑generation architectures such as world models may indicate where Nabla aims to position its technology stack, potentially aligning the company with hospitals’ near‑term AI adoption roadmaps and creating opportunities in operational efficiency and clinical quality markets.